نتایج جستجو برای: 4 dihydroquinoline

تعداد نتایج: 1303673  

2013
Tatiana Gorojankina Lucile Hoch Hélène Faure Hermine Roudaut Elisabeth Traiffort Angèle Schoenfelder Nicolas Girard André Mann Fabrizio Manetti Antonio Solinas Elena Petricci Maurizio Taddei Martial Ruat

Activation of the Smoothened (Smo) receptor mediates Hedgehog (Hh) signaling. Hh inhibitors are in clinical trials for cancer, and small-molecule Smo agonists may have therapeutic interests in regenerative medicine. Here, we have generated and validated a pharmacophoric model for Smo agonists and used this model for the virtual screening of a library of commercially available compounds. Among t...

Journal: :Journal of bacteriology 1997
B Rosche B Tshisuaka B Hauer F Lingens S Fetzner

2-Oxo-1,2-dihydroquinoline 8-monooxygenase, an enzyme involved in quinoline degradation by Pseudomonas putida 86, had been identified as a class IB two-component nonheme iron oxygenase based on its biochemical and biophysical properties (B. Rosche, B. Tshisuaka, S. Fetzner, and F. Lingens, J. Biol. Chem. 270:17836-17842, 1995). The genes oxoR and oxoO, encoding the reductase and the oxygenase c...

Journal: :Molecular pharmacology 2013
Tatiana Gorojankina Lucile Hoch Hélène Faure Hermine Roudaut Elisabeth Traiffort Angèle Schoenfelder Nicolas Girard André Mann Fabrizio Manetti Antonio Solinas Elena Petricci Maurizio Taddei Martial Ruat

Activation of the Smoothened (Smo) receptor mediates Hedgehog (Hh) signaling. Hh inhibitors are in clinical trials for cancer, and small-molecule Smo agonists may have therapeutic interests in regenerative medicine. Here, we have generated and validated a pharmacophoric model for Smo agonists and used this model for the virtual screening of a library of commercially available compounds. Among t...

2017
Mengqiao Wang Robert J Lee Ye Bi Lianlian Li Guodong Yan Jiahui Lu Qingfan Meng Lesheng Teng Jing Xie

A series of 1,2-dihydroquinoline derivatives were synthesized and evaluated for cytotoxicity in HeLa, Hep G2 and 6HEK-293T cell lines. EEDQ2 was identified as a promising anti-cancer agent with low IC50 in HeLa (18.55μg/ml) and Hep G2 (14.53μg/ml) cells. For improving the antitumor activity and tumor selectivity of EEDQ2, we prepared transferrin (Tf)-modified liposomes (LPs) to deliver EEDQ2. W...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید